These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16613851)

  • 1. MOZ-TIF2 alters cofactor recruitment and histone modification at the RARbeta2 promoter: differential effects of MOZ fusion proteins on CBP- and MOZ-dependent activators.
    Collins HM; Kindle KB; Matsuda S; Ryan C; Troke PJF; Kalkhoven E; Heery DM
    J Biol Chem; 2006 Jun; 281(25):17124-17133. PubMed ID: 16613851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.
    Kindle KB; Troke PJ; Collins HM; Matsuda S; Bossi D; Bellodi C; Kalkhoven E; Salomoni P; Pelicci PG; Minucci S; Heery DM
    Mol Cell Biol; 2005 Feb; 25(3):988-1002. PubMed ID: 15657427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
    Yin H; Glass J; Blanchard KL
    Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
    Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
    Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MOZ-TIF2-mediated destruction of CBP/p300 is blocked by calpain inhibitor 2.
    Kindle KB; Collins HM; Heery DM
    Leukemia; 2010 Jul; 24(7):1359-61. PubMed ID: 20485379
    [No Abstract]   [Full Text] [Related]  

  • 6. Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.
    Kitabayashi I; Aikawa Y; Nguyen LA; Yokoyama A; Ohki M
    EMBO J; 2001 Dec; 20(24):7184-96. PubMed ID: 11742995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A MOZ-TIF2 leukemia mouse model displays KAT6-dependent H3K23 propionylation and overexpression of a set of active developmental genes.
    Smolko AE; Sullivan DW; Olsen SN; Kang H; Whedon SD; Baell JB; Cole PA; Armstrong SA; Kuroda MI
    Proc Natl Acad Sci U S A; 2024 Jun; 121(26):e2405905121. PubMed ID: 38889153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOZ and MOZ-CBP cooperate with NF-kappaB to activate transcription from NF-kappaB-dependent promoters.
    Chan EM; Chan RJ; Comer EM; Goulet RJ; Crean CD; Brown ZD; Fruehwald AM; Yang Z; Boswell HS; Nakshatri H; Gabig TG
    Exp Hematol; 2007 Dec; 35(12):1782-92. PubMed ID: 17920756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MOZ fusion proteins in acute myeloid leukaemia.
    Troke PJ; Kindle KB; Collins HM; Heery DM
    Biochem Soc Symp; 2006; (73):23-39. PubMed ID: 16626284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.
    Carapeti M; Aguiar RC; Goldman JM; Cross NC
    Blood; 1998 May; 91(9):3127-33. PubMed ID: 9558366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.
    Liang J; Prouty L; Williams BJ; Dayton MA; Blanchard KL
    Blood; 1998 Sep; 92(6):2118-22. PubMed ID: 9731070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain-PHD finger protein 1 is critical for leukemogenesis associated with MOZ-TIF2 fusion.
    Shima H; Yamagata K; Aikawa Y; Shino M; Koseki H; Shimada H; Kitabayashi I
    Int J Hematol; 2014 Jan; 99(1):21-31. PubMed ID: 24258712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.
    Largeot A; Perez-Campo FM; Marinopoulou E; Lie-a-Ling M; Kouskoff V; Lacaud G
    Exp Hematol; 2016 Apr; 44(4):231-7.e4. PubMed ID: 26854485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PML-RARalpha and AML1-ETO translocations are rarely associated with methylation of the RARbeta2 promoter.
    Tabe Y; Konopleva M; Kondo Y; Contractor R; Jin L; Ruvolo V; Tsutsumi-Ishii Y; Miyake K; Miyake N; Ohsaka A; Nagaoka I; Issa JP; Andreeff M
    Ann Hematol; 2006 Oct; 85(10):689-704. PubMed ID: 16832676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2.
    Aikawa Y; Katsumoto T; Zhang P; Shima H; Shino M; Terui K; Ito E; Ohno H; Stanley ER; Singh H; Tenen DG; Kitabayashi I
    Nat Med; 2010 May; 16(5):580-5, 1p following 585. PubMed ID: 20418886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of the histone acetyltransferase monocytic leukemia zinc finger protein in normal and malignant hematopoiesis.
    Katsumoto T; Yoshida N; Kitabayashi I
    Cancer Sci; 2008 Aug; 99(8):1523-7. PubMed ID: 18754862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12].
    Pébusque MJ; Chaffanet M; Popovici C; Birnbaum D
    Bull Cancer; 2000 Dec; 87(12):887-94. PubMed ID: 11174118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recruitment of nuclear factor Y to the inverted CCAAT element (ICE) by c-Jun and E1A stimulates basal transcription of the bone sialoprotein gene in osteosarcoma cells.
    Su M; Bansal AK; Mantovani R; Sodek J
    J Biol Chem; 2005 Nov; 280(46):38365-75. PubMed ID: 16087680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of HIPK1 and HIPK2 in AML1- and p300-dependent transcription, hematopoiesis and blood vessel formation.
    Aikawa Y; Nguyen LA; Isono K; Takakura N; Tagata Y; Schmitz ML; Koseki H; Kitabayashi I
    EMBO J; 2006 Sep; 25(17):3955-65. PubMed ID: 16917507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
    Tam WF; Hähnel PS; Schüler A; Lee BH; Okabe R; Zhu N; Pante SV; Raffel G; Mercher T; Wernig G; Bockamp E; Sasca D; Kreft A; Robinson GW; Hennighausen L; Gilliland DG; Kindler T
    Cancer Res; 2013 Jan; 73(1):373-84. PubMed ID: 23149921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.